BioCorRx (BioCorRx) FCF Margin % : -2,810.53% (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is BioCorRx FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BioCorRx's Free Cash Flow for the three months ended in Dec. 2023 was $-0.53 Mil. BioCorRx's Revenue for the three months ended in Dec. 2023 was $0.02 Mil. Therefore, BioCorRx's FCF Margin % for the quarter that ended in Dec. 2023 was -2,810.53%.

As of today, BioCorRx's current FCF Yield % is -28.04%.

The historical rank and industry rank for BioCorRx's FCF Margin % or its related term are showing as below:

BICX' s FCF Margin % Range Over the Past 10 Years
Min: -7475 Med: -726.71 Max: 14.35
Current: -2083.15

During the past 13 years, the highest FCF Margin % of BioCorRx was 14.35%. The lowest was -7475.00%. And the median was -726.71%.

BICX's FCF Margin % is ranked worse than
98.19% of 662 companies
in the Healthcare Providers & Services industry
Industry Median: 1.385 vs BICX: -2083.15

BioCorRx FCF Margin % Historical Data

The historical data trend for BioCorRx's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioCorRx FCF Margin % Chart

BioCorRx Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-1,275.00

-1,756.91

-7,475.00

-954.21

-2,082.02

BioCorRx Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-542.17	-992.50	-2,860.00	-3,510.00	-2,810.53

Competitive Comparison of BioCorRx's FCF Margin %

For the Medical Care Facilities subindustry, BioCorRx's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioCorRx's FCF Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BioCorRx's FCF Margin % distribution charts can be found below:

* The bar in red indicates where BioCorRx's FCF Margin % falls into.

BioCorRx FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

BioCorRx's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-1.853	/	0.089
	=	-2,082.02 %

BioCorRx's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-0.534	/	0.019
	=	-2,810.53 %

BioCorRx FCF Margin % Related Terms

Thank you for viewing the detailed overview of BioCorRx's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

BioCorRx (BioCorRx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioCorRx Inc (OTCPK:BICX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2390 East Orangewood Avenue, Suite 500, Anaheim, CA, USA, 92806

Website

https://www.biocorrx.com

BioCorRx Inc through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders. The BioCorRx Recovery Program is a non-addictive, medication-assisted treatment program for substance abuse that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application.

Executives

Louis C. Lucido	director	2390 EAST ORANGEWOOD AVENUE, SUITE 500, ANAHEIM CA 92806
Joseph J Galligan	director, 10 percent owner	333 SOUTH GRAND AVENUE, 18TH FLOOR, LOS ANGELES CA 90071
Harsha Murthy	director	5209 38TH STREET,NW, WASHINGTON DC 20015
Luisa Ingargiola	director	4826 BLUE JAY CIRCLE, PALM HARBOR FL 34683
Thomas Patrick Welch	officer: Vice President of Operations	10453 SARAH ST., TOLUCA LAKE CA 91602
Kent Emry	director, officer: Chief Executive Officer	2390 EAST ORANGEWOOD AVENUE, SUITE 500, ANAHEIM CA 92806
Brady James Granier	director	13024 DELANO STREET, VALLEY GLEN CA 91401
Lourdes Felix	director, officer: Chief Financial Officer	15 CALLE VERANO, RANCHO SANTA MARGARITA CA 92688
Jorge Jr Andrade	director, officer: Chief Executive Officer	PO BOX 5366, SANTA ANA CA 92704
Muller Neil Terrence Mr	director, officer: President	13231 SANDHURST PLACE, SANTA ANA CA 92705